Fingerprint
Dive into the research topics where Anand B Karnad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors
Banwait, R., Ko, H., Michalek, J., Liu, Q., Lathrop, K., Bowhay-Carnes, E., Fotopoulos, G., Sarantopoulos, J., Elledge, R., Taverna, J., Karnad, A., Siziopikou, K. P. & Kaklamani, V., Aug 15 2025, In: International Journal of Cancer. 157, 4, p. 752-759 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Classical Hematology Referrals at an National Cancer Institute–Designated Cancer Center: Lessons Learned
West, C. V., Butler, M. J., Kaur, S., Bowhay-Carnes, E. & Karnad, A. B., Jan 1 2024, In: JCO Oncology Practice. 20, 1, p. 131-135 5 p.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Scopus citations -
First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL
Duque, A. E. D., Ferrari, P. S. S. M., Ethiraj, P., Jaafar, C., Qiu, Z., Holder, K., Butler, M. J., Huelgas-Morales, G., Karnad, A., Dahia, P. L. M. & Aguiar, R. C. T., Nov 2024, In: Cancers. 16, 22, 3857.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching
Chen, C., Zhao, S., Zhao, X., Cao, L., Karnad, A., Kumar, A. P. & Freeman, J. W., Aug 2022, In: Cell Death and Disease. 13, 8, 682.Research output: Contribution to journal › Article › peer-review
Open Access42 Link opens in a new tab Scopus citations -
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study
Hamadani, M., Collins, G. P., Caimi, P. F., Samaniego, F., Spira, A., Davies, A., Radford, J., Menne, T., Karnad, A., Zain, J. M., Fields, P., Havenith, K., Cruz, H. G., He, S., Boni, J., Feingold, J., Wuerthner, J. & Horwitz, S., Jun 2021, In: The Lancet Haematology. 8, 6, p. e433-e445Research output: Contribution to journal › Article › peer-review
Open Access81 Link opens in a new tab Scopus citations